Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | +1.40% | +1.10% | -2.02% |
Feb. 13 | Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for Its Phase 1 Trial of Pas-004 | CI |
Jan. 12 | Top Premarket Decliners | MT |
Financials (USD)
Sales 2021 | 0.02 | Sales 2022 | 0.49 | Capitalization | 18.77M |
---|---|---|---|---|---|
Net income 2021 | -2M | Net income 2022 | -13M | EV / Sales 2021 | -944,383,814 x |
Net cash position 2021 | 52.97M | Net cash position 2022 | 32.22M | EV / Sales 2022 | -27,645,426 x |
P/E ratio 2021 |
-8.47
x | P/E ratio 2022 |
-1.16
x | Employees | 15 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
1 day | +1.40% | ||
1 week | +1.10% | ||
Current month | -9.37% | ||
1 month | -4.60% | ||
3 months | -7.05% | ||
6 months | -19.53% | ||
Current year | -2.02% |
Managers | Title | Age | Since |
---|---|---|---|
Tiago Marques
CEO | Chief Executive Officer | 47 | 20-07-31 |
Director of Finance/CFO | 46 | 22-06-30 | |
Graeme Currie
PRN | Corporate Officer/Principal | 58 | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 77 | 19-12-31 | |
Alfred Novak
BRD | Director/Board Member | 76 | 22-09-13 |
Emer Leahy
BRD | Director/Board Member | 58 | 21-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7.25 | +1.40% | 1,731 |
24-03-27 | 7.15 | -2.05% | 1,502 |
24-03-26 | 7.3 | +2.37% | 566 |
24-03-25 | 7.131 | +6.40% | 752 |
24-03-22 | 6.702 | -6.55% | 939 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.02% | 7.45M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |